Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+8.78%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$18.4B
AUM Growth
+$3.1B
(+20%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
10.55%
Top 10 Holdings %
Top 10 Hldgs %
22.32%
Holding
1,150
New
118
Increased
809
Reduced
144
Closed
21
Top Buys
| 1 |
Apple
AAPL
|
$101M |
| 2 |
Microsoft
MSFT
|
$97.9M |
| 3 |
Amazon
AMZN
|
$75.4M |
| 4 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$57.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$46.2M |
Top Sells
| 1 |
Alibaba
BABA
|
$98.1M |
| 2 |
Vuzix
VUZI
|
$38.1M |
| 3 |
3D Systems Corporation
DDD
|
$23.4M |
| 4 |
Microvision
MVIS
|
$22.9M |
| 5 |
Ambarella
AMBA
|
$10.3M |
Sector Composition
| 1 | Technology | 24.43% |
| 2 | Healthcare | 12.37% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 11.94% |
| 5 | Communication Services | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
uniQure
QURE
$973M
| $280K | ﹤0.01% |
9,093
+1,008
| +12% | +$31K |
|
1052
Upstart Holdings
UPST
$6.34B
| $276K | ﹤0.01% |
+2,207
| New | +$276K |
|
1053
Bit Digital
BTBT
$797M
| $273K | ﹤0.01% |
+39,949
| New | +$273K |
|
1054
Repare Therapeutics
RPTX
$72.6M
| $272K | ﹤0.01% |
+8,736
| New | +$272K |
|
1055
Ultragenyx Pharmaceutical
RARE
$3.01B
| $262K | ﹤0.01% |
2,745
-435
| -14% | -$41.5K |
|
|
ADAP
1056
Adaptimmune Therapeutics
ADAP
$13.5M
| $259K | ﹤0.01% |
60,848
-16,072
| -21% | -$68.4K |
|
1057
Ultrapar
UGP
$3.88B
| $259K | ﹤0.01% |
+68,872
| New | +$259K |
|
1058
Mercury Insurance
MCY
$4.37B
| $257K | ﹤0.01% |
+3,963
| New | +$257K |
|
1059
Q2 Holdings
QTWO
$4.82B
| $257K | ﹤0.01% |
2,508
+613
| +32% | +$62.8K |
|
1060
Alaunos Therapeutics
TCRT
$4.27M
| $256K | ﹤0.01% |
647
-249
| -28% | -$98.5K |
|
|
TCRR
1061
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $255K | ﹤0.01% |
15,521
+2,822
| +22% | +$46.4K |
|
1062
Ionis Pharmaceuticals
IONS
$9.46B
| $254K | ﹤0.01% |
6,368
-26,142
| -80% | -$1.04M |
|
1063
Xencor
XNCR
$597M
| $253K | ﹤0.01% |
7,342
-1,673
| -19% | -$57.7K |
|
|
LAND
1064
Gladstone Land Corp
LAND
$327M
| $250K | ﹤0.01% |
10,398
+2,184
| +27% | +$52.5K |
|
1065
Merus
MRUS
$5.01B
| $249K | ﹤0.01% |
+11,822
| New | +$249K |
|
1066
Agilysys
AGYS
$3.04B
| $246K | ﹤0.01% |
4,324
-419
| -9% | -$23.8K |
|
1067
HealthEquity
HQY
$8.42B
| $246K | ﹤0.01% |
3,053
-242
| -7% | -$19.5K |
|
1068
Ligand Pharmaceuticals
LGND
$3.27B
| $246K | ﹤0.01% |
3,009
-2,403
| -44% | -$196K |
|
1069
Maravai LifeSciences
MRVI
$341M
| $244K | ﹤0.01% |
+5,841
| New | +$244K |
|
|
ORTX
1070
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $244K | ﹤0.01% |
5,563
-2,674
| -32% | -$117K |
|
|
BBBY
1071
Bed Bath & Beyond, Inc.
BBBY
$503M
| $240K | ﹤0.01% |
2,607
-4,118
| -61% | -$379K |
|
|
SNR
1072
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $239K | ﹤0.01% |
27,190
+1,292
| +5% | +$11.4K |
|
1073
ING
ING
$71.7B
| $235K | ﹤0.01% |
17,742
-4,890
| -22% | -$64.8K |
|
1074
Novartis
NVS
$249B
| $234K | ﹤0.01% |
2,569
-524
| -17% | -$47.7K |
|
|
BPYU
1075
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $231K | ﹤0.01% |
12,216
| – | – |
|